Company Filing History:
Years Active: 1992
Title: Christopher A. Palabrica: Innovator in LHRH Antagonists
Introduction
Christopher A. Palabrica is a notable inventor based in River Hills, Wisconsin. He has made significant contributions to the field of biochemistry, particularly in the development of LHRH antagonists. His innovative work has led to advancements in medical treatments and therapies.
Latest Patents
Christopher A. Palabrica holds a patent for "Octapeptide LHRH antagonists." This invention relates to novel LHRH analogs, which include 'pseudo' hexapeptide, heptapeptide, octapeptide, and nonapeptide analogs of LHRH. The analogs are characterized by the elimination of certain amino acids, with the remaining peptides linked to various carboxylic acids that replace amino acids 1, 2, or 3 in LHRH. This patent showcases his expertise in peptide chemistry and its applications in medicine. He has 1 patent to his name.
Career Highlights
Christopher has worked with Tap Pharmaceuticals, Inc., where he has been instrumental in research and development. His role at the company has allowed him to collaborate with other talented professionals in the field. His work has contributed to the advancement of pharmaceutical products that address critical health issues.
Collaborations
Some of his notable coworkers include Fortuna Haviv and Jonathan Greer. Their collaborative efforts have further enhanced the research and development initiatives at Tap Pharmaceuticals, Inc.
Conclusion
Christopher A. Palabrica is a distinguished inventor whose work in LHRH antagonists has made a significant impact in the field of biochemistry. His innovative contributions continue to influence medical research and development.